However, the rates of positive ezrin, ezrinThr-567 and ezrinTyr-353 expression were significantly higher in NSCLC than in the adjacent non-tumor tissues and normal lung tissue counterparts, with rates of 62.7%, 63.3% and 71.3% in NSCLC, respectively (P < 0.01). This evidence concerns the gene EZR and non-small cell lung carcinoma.